Form 4 for CLX Clorox
Accepted 2024-10-08 00:00:00 ET · period of report 2024-10-04 · accession 0001225208-24-009229 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-10-08 | 2024-10-04 | CLX | Marriner Kirsten | EVP - CHRO | F - Tax | $161.57 | -2,958 | 35.2K | -8% | -$477.9K |
| 2024-10-08 | 2024-10-04 | CLX | Marriner Kirsten | EVP - CHRO | A - Grant | $161.57 | +6,898 | 38.1K | +22% | +$1.11M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-04 | F | D | 437 | $161.57 | 37,693 | D | — | — | |
| 2 | Common | Common Stock | 2024-10-04 | F | D | 2,521 | $161.57 | 35,172 | D | — | — | (F4) Includes 227 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. |
| 3 | Common | Common Stock | 2024-10-04 | A | A | 6,898 | $161.57 | 38,130 | D | — | — |